{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:02:50Z","timestamp":1786122170565,"version":"build-2736575974"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["F31MH132187"],"award-info":[{"award-number":["F31MH132187"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Psychiatric medication utilization studies rarely identify transgender and gender diverse (TGD) people, masking TGD health inequities. This study assessed antidepressant prescription fill patterns and their predictors among a privately insured TGD sample with newly dispensed anti-depressants after a recent depression or anxiety diagnosis from Merative MarketScan commercial insurance claims from 2007 to 2021. We measured trajectories of antidepressants utilization over 6-months using group-based trajectory modeling (GBTM), then identified demographic and clinical predictors of medication utilization group membership. Among 2499 TGD people with depression or anxiety, we found three anti-depressant dispensing trajectory groups (short-term [21.1%], decreasing [32.3%], and long-term [46.6%]). TGD people with previous chronic co-morbidities or emergency department visits had an increased probability of shorter-term antidepressant dispensing compared to long-term dispensing. TGD people under the age of 25 and those with previous psychotherapy treatment were less likely to have shorter-term anti-depressant dispensing than those with older ages (25\u201364) and those without prior psychotherapy. This study provides real-world evidence of distinct anti-depressant dispensing patterns and predictive factors associated with shorter-term dispensing among TGD people. Policymakers, providers, and advocacy groups can utilize findings to inform tailored strategies to improve sustained antidepressant use among TGD people living with mental health conditions.<\/jats:p>","DOI":"10.1038\/s41598-026-51351-y","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T12:35:37Z","timestamp":1779971737000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trajectories of antidepressant dispensing among privately insured transgender people in the United States"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4332-6310","authenticated-orcid":false,"given":"Theo Gabriel","family":"Beltran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-9538","authenticated-orcid":false,"given":"Brian W.","family":"Pence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2141-8882","authenticated-orcid":false,"given":"Virginia","family":"Pate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1108-0689","authenticated-orcid":false,"given":"Jennifer L.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6541-3787","authenticated-orcid":false,"given":"Tonia C.","family":"Poteat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1611-5393","authenticated-orcid":false,"given":"Kathleen C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3944-3912","authenticated-orcid":false,"given":"Shabbar I.","family":"Ranapurwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3579-3608","authenticated-orcid":false,"given":"Derrick D.","family":"Matthews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6945-2713","authenticated-orcid":false,"given":"Juan M.","family":"Hincapie-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"issue":"1","key":"51351_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1089\/trgh.2016.0031","volume":"1","author":"K Proctor","year":"2016","unstructured":"Proctor, K., Haffer, S. C., Ewald, E., Hodge, C. & James, C. V. Identifying the transgender population in the medicare program. Transgender Health. 1 (1), 250\u2013265 (2016).","journal-title":"Transgender Health"},{"issue":"1","key":"51351_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13293-020-00332-5","volume":"11","author":"HA James","year":"2020","unstructured":"James, H. A. et al. A community-based study of demographics, medical and psychiatric conditions, and gender dysphoria\/incongruence treatment in transgender\/gender diverse individuals. Biol. Sex. Differ. 11 (1), 55 (2020).","journal-title":"Biol. Sex. Differ."},{"issue":"10042","key":"51351_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","volume":"388","author":"SL Reisner","year":"2016","unstructured":"Reisner, S. L. et al. Global health burden and needs of transgender populations: a review. Lancet Lond. Engl. 388 (10042), 412\u2013436 (2016).","journal-title":"Lancet Lond. Engl."},{"issue":"4","key":"51351_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/09540121.2013.841832","volume":"26","author":"T Nemoto","year":"2014","unstructured":"Nemoto, T., B\u00f6deker, B., Iwamoto, M. & Sakata, M. Practices of receptive and insertive anal sex among transgender women in relation to partner types, sociocultural factors, and background variables. AIDS Care. 26 (4), 434\u2013440 (2014).","journal-title":"AIDS Care"},{"key":"51351_CR5","unstructured":"Brooks, V. R. Minority stress and lesbian women. (1981). https:\/\/api.semanticscholar.org\/CorpusID:144044170"},{"issue":"5","key":"51351_CR6","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1037\/0033-2909.129.5.674","volume":"129","author":"IH Meyer","year":"2003","unstructured":"Meyer, I. H. Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: Conceptual issues and research evidence. Psychol. Bull. 129 (5), 674\u2013697 (2003).","journal-title":"Psychol. Bull."},{"issue":"1","key":"51351_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1037\/sgd0000081","volume":"2","author":"RJ Testa","year":"2015","unstructured":"Testa, R. J., Habarth, J., Peta, J., Balsam, K. & Bockting, W. Development of the gender minority stress and resilience measure. Psychol. Sex. Orientat. Gend. Divers. 2 (1), 65\u201377 (2015).","journal-title":"Psychol. Sex. Orientat. Gend. Divers."},{"issue":"3","key":"51351_CR8","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1300\/J082v51n03_04","volume":"51","author":"K Clements-Nolle","year":"2006","unstructured":"Clements-Nolle, K., Marx, R. & Katz, M. Attempted suicide among transgender persons. J. Homosex. 51 (3), 53\u201369 (2006).","journal-title":"J. Homosex"},{"key":"51351_CR9","unstructured":"James, S. E., Herman, J., Keisling, M., Mottet, L. & Anafi, M. 2015 U.S. Transgender Survey (USTS) (Inter-university Consortium for Political and Social Research [distributor], 2019)."},{"issue":"3","key":"51351_CR10","doi-asserted-by":"publisher","first-page":"e0299373","DOI":"10.1371\/journal.pone.0299373","volume":"19","author":"AI Scheim","year":"2024","unstructured":"Scheim, A. I. et al. Health status of transgender people globally: A systematic review of research on disease burden and correlates. PLoS One. 19 (3), e0299373 (2024).","journal-title":"PLoS One"},{"key":"51351_CR11","unstructured":"https:\/\/www.apa.org [Internet]. [cited 2023 Jan 20]. Depression Treatments for Adults. https:\/\/www.apa.org\/depression-guideline\/adults"},{"key":"51351_CR12","unstructured":"Gelenberg, A. J. et al. American Psychiatric Association. Practice guidelines for the treatment of patients with major depressive disorder [Internet]. 2010 [cited 2022 Dec 16]. https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/mdd-1410197717630.pdf"},{"issue":"10","key":"51351_CR13","doi-asserted-by":"publisher","first-page":"725","DOI":"10.7326\/0003-4819-149-10-200811180-00007","volume":"149","author":"A Qaseem","year":"2008","unstructured":"Qaseem, A. et al. Using second-generation antidepressants to treat depressive disorders: A clinical practice guideline from the American College of Physicians. Ann. Intern. Med. 149 (10), 725\u2013733 (2008).","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"51351_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1034\/j.1600-0447.2002.1e003.x","volume":"105","author":"F Colom","year":"2002","unstructured":"Colom, F. & Vieta, E. Non-adherence in psychiatric disorders: Misbehaviour or clinical feature? Acta Psychiatr. Scand. 105 (3), 161\u2013163 (2002).","journal-title":"Acta Psychiatr Scand."},{"key":"51351_CR15","unstructured":"Compliance With Medication Regimens for Mental and Physical Disorders. | Psychiatric Services [Internet]. [cited 2023 Jan 31]. https:\/\/ps-psychiatryonline-org.libproxy.lib.unc.edu\/doi\/10.1176\/ps.49.2.196?url_ver=Z39.88-2003_id=ori:rid:crossref.org_dat=cr_pub%20%200pubmed"},{"key":"51351_CR16","unstructured":"Tackling nonadherence in psychiatric disorders: current opinion - PMC [Internet]. [cited 2023 Jan 31]. https:\/\/www-ncbi-nlm-nih-gov.libproxy.lib.unc.edu\/pmc\/articles\/PMC4062556\/"},{"key":"51351_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13643-018-0676-y","volume":"7","author":"A Semahegn","year":"2018","unstructured":"Semahegn, A. et al. Psychotropic medication non-adherence and associated factors among adult patients with major psychiatric disorders: A protocol for a systematic review. Syst. Rev. 7, 10 (2018).","journal-title":"Syst. Rev."},{"issue":"8","key":"51351_CR18","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1002\/pds.1230","volume":"15","author":"SE Andrade","year":"2006","unstructured":"Andrade, S. E., Kahler, K. H., Frech, F. & Chan, K. A. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol. Drug Saf. 15 (8), 565\u2013574 (2006).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"8","key":"51351_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1176\/appi.ajp.2019.19010080","volume":"177","author":"R Br\u00e4nstr\u00f6m","year":"2020","unstructured":"Br\u00e4nstr\u00f6m, R. & Pachankis, J. E. Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: A total population study. Am. J. Psychiatry. 177 (8), 727\u2013734 (2020).","journal-title":"Am. J. Psychiatry"},{"key":"51351_CR20","first-page":"198","volume-title":"Adherence to long-term therapies: evidence for action","year":"2003","unstructured":"Sabat\u00e9 E, World Health Organization, editors. Adherence to Long-term Therapies: Evidence for Action, 198 (World Health Organization, 2003)."},{"issue":"8","key":"51351_CR21","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/09540121.2016.1146401","volume":"28","author":"GN Baguso","year":"2016","unstructured":"Baguso, G. N., Gay, C. L. & Lee, K. A. Medication adherence among transgender women living with HIV. AIDS Care. 28 (8), 976\u2013981 (2016).","journal-title":"AIDS Care"},{"issue":"3","key":"51351_CR22","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.jana.2010.01.005","volume":"21","author":"JM Sevelius","year":"2010","unstructured":"Sevelius, J. M., Carrico, A. & Johnson, M. O. Antiretroviral therapy adherence among transgender women living with HIV. J. Assoc. Nurses AIDS Care JANAC. 21 (3), 256\u2013264 (2010).","journal-title":"J. Assoc. Nurses AIDS Care JANAC"},{"key":"51351_CR23","unstructured":"The, I. B. M. MarketScan Commercial Claims and Encounters Database | Center for Applied Studies in Health Economics [Internet]. [cited 2023 Feb 17]. https:\/\/cashe.psu.edu\/resources\/marketscan\/"},{"key":"51351_CR24","unstructured":"MarketScan | Administrative Claims Records | Information on Data Sources |. Vision and Eye Health Surveillance System | Vision Health Initiative (VHI) | CDC [Internet]. 2021 [cited 2023 Feb 17]. https:\/\/www.cdc.gov\/visionhealth\/vehss\/data\/claims\/marketscan.html"},{"issue":"3","key":"51351_CR25","doi-asserted-by":"publisher","first-page":"e5732","DOI":"10.1002\/pds.5732","volume":"33","author":"TG Beltran","year":"2024","unstructured":"Beltran, T. G., Lett, E., Poteat, T. & Hincapie-Castillo, J. M. Computational phenotyping within electronic healthcare data to identify transgender people in the United States: A narrative review. Pharmacoepidemiol. Drug Saf. 33 (3), e5732 (2024).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"6","key":"51351_CR26","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1089\/lgbt.2018.0238","volume":"6","author":"A McDowell","year":"2019","unstructured":"McDowell, A., Progovac, A. M., Cook, B. L. & Rose, S. Estimating the health status of privately insured gender minority children and adults. LGBT Health. 6 (6), 289\u2013296 (2019).","journal-title":"LGBT Health"},{"key":"51351_CR27","doi-asserted-by":"publisher","unstructured":"Beltran, T. G. et al. Phenotyping to identify mental health trends of transgender individuals using private commercial insurance data in the United States. LGBT Health. Apr 21 [cited 2025 May 28]; (2025). https:\/\/doi.org\/10.1089\/lgbt.2024.0250","DOI":"10.1089\/lgbt.2024.0250"},{"issue":"10","key":"51351_CR28","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/MLR.0000000000001362","volume":"58","author":"GK Jasuja","year":"2020","unstructured":"Jasuja, G. K. et al. Beyond gender identity disorder diagnosis codes: An examination of additional methods to identify transgender individuals in administrative databases. Med. Care. 58 (10), 903\u2013911 (2020).","journal-title":"Med. Care"},{"key":"51351_CR29","unstructured":"Chronic Conditions Warehouse. Other Chronic Health, Mental Health, and Potentially Disabling Conditions Algorithms- Anxiety Disorders [Internet]. Chronic Conditions Warehouse; 2022 [cited 2022 Mar 17]. https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories-other"},{"key":"51351_CR30","unstructured":"Chronic Conditions Algorithms. 27 CCW Chronic Conditions Algorithms- Depression [Internet]. Chronic Conditions Warehouse; 2022 [cited 2022 Mar 17]. https:\/\/www2.ccwdata.org\/web\/guest\/condition-categories-chronic"},{"issue":"6","key":"51351_CR31","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/pop.2011.0084","volume":"15","author":"R Alaghehbandan","year":"2012","unstructured":"Alaghehbandan, R., Macdonald, D., Barrett, B., Collins, K. & Chen, Y. Using administrative databases in the surveillance of depressive disorders\u2013case definitions. Popul. Health Manag. 15 (6), 372\u2013380 (2012).","journal-title":"Popul. Health Manag"},{"key":"51351_CR32","doi-asserted-by":"publisher","unstructured":"Chen, Z., Roy, K., Khushalani, J. S. & Puddy, R. W. Trend in rural-urban disparities in access to outpatient mental health services among US adults aged 18\u201364 with employer-sponsored insurance: 2005\u20132018. J. Rural Health [cited 2022 Mar 4] https:\/\/onlinelibrary-wiley-com.libproxy.lib.unc.edu\/doi\/abs\/https:\/\/doi.org\/10.1111\/jrh.12644","DOI":"10.1111\/jrh.12644"},{"key":"51351_CR33","doi-asserted-by":"crossref","unstructured":"Dean, L. T. et al. Economic burden among gay, bisexual, and other men who have sex with men living with HIV or living without HIV in the multicenter AIDS cohort study. J. Acquir. Immune Defic. Syndr.. 85(4), 436\u2013443 (1999).","DOI":"10.1097\/QAI.0000000000002478"},{"issue":"5","key":"51351_CR34","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1007\/s40263-017-0417-0","volume":"31","author":"KR Keyloun","year":"2017","unstructured":"Keyloun, K. R. et al. Adherence and persistence across antidepressant therapeutic classes: A retrospective claims analysis among insured US patients with major depressive disorder (MDD). CNS Drugs. 31 (5), 421\u2013432 (2017).","journal-title":"CNS Drugs"},{"issue":"11","key":"51351_CR35","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2165\/00023210-200822110-00005","volume":"22","author":"DV Sheehan","year":"2008","unstructured":"Sheehan, D. V. et al. Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and\/or anxiety disorders. CNS Drugs. 22 (11), 963\u2013973 (2008).","journal-title":"CNS Drugs"},{"issue":"11","key":"51351_CR36","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamapsychiatry.2017.3047","volume":"74","author":"JA Sirey","year":"2017","unstructured":"Sirey, J. A. et al. Adherence to depression treatment in primary care: A randomized clinical trial. JAMA Psychiatry. 74 (11), 1129\u20131135 (2017).","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"51351_CR37","doi-asserted-by":"publisher","first-page":"e0238623","DOI":"10.1371\/journal.pone.0238623","volume":"15","author":"NJ Ji","year":"2020","unstructured":"Ji, N. J. & Hong, Y. P. Effect of income level on adherence to antidepressant treatment in first onset depression outpatients. PLoS One. 15 (9), e0238623 (2020).","journal-title":"PLoS One"},{"key":"51351_CR38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3389\/fpsyt.2020.00113","volume":"11","author":"JM Zito","year":"2020","unstructured":"Zito, J. M., Pennap, D. & Safer, D. J. Antidepressant use in medicaid-insured youth: Trends, covariates, and future research needs. Front. Psychiatry. 11, 113 (2020).","journal-title":"Front. Psychiatry"},{"issue":"8","key":"51351_CR39","first-page":"736","volume":"24","author":"WD Lohr","year":"2018","unstructured":"Lohr, W. D. et al. Psychotropic polypharmacy among children and youth receiving medicaid, 2012\u20132015. J. Manag. Care Spec. Pharm. 24 (8), 736\u2013744 (2018).","journal-title":"J. Manag Care Spec. Pharm."},{"issue":"2","key":"51351_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.15386\/mpr-1201","volume":"92","author":"LA Anghel","year":"2019","unstructured":"Anghel, L. A., Farcas, A. M. & Oprean, R. N. An overview of the common methods used to measure treatment adherence. Med. Pharm. Rep. 92 (2), 117\u2013122 (2019). 2019\/04\/25.","journal-title":"Med. Pharm. Rep."},{"key":"51351_CR41","unstructured":"Nau, D. P. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence."},{"issue":"7","key":"51351_CR42","first-page":"457","volume":"15","author":"NK Choudhry","year":"2009","unstructured":"Choudhry, N. K. et al. Measuring concurrent adherence to multiple related medications. Am. J. Manag Care. 15 (7), 457\u2013464 (2009).","journal-title":"Am. J. Manag Care"},{"issue":"10","key":"51351_CR43","doi-asserted-by":"publisher","first-page":"4427","DOI":"10.1111\/bcp.15391","volume":"88","author":"LL Dalli","year":"2022","unstructured":"Dalli, L. L. et al. Towards better reporting of the proportion of days covered method in cardiovascular medication adherence: A scoping review and new tool TEN-SPIDERS. Br. J. Clin. Pharmacol. 88 (10), 4427\u20134442 (2022).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"6","key":"51351_CR44","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1002\/da.21952","volume":"29","author":"CH Wu","year":"2012","unstructured":"Wu, C. H., Farley, J. F. & Gaynes, B. N. The association between antidepressant dosage titration and medication adherence among patients with depression. Depress. Anxiety. 29 (6), 506\u2013514 (2012).","journal-title":"Depress. Anxiety"},{"issue":"5","key":"51351_CR45","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40 (5), 373\u2013383 (1987).","journal-title":"J. Chronic Dis."},{"issue":"9","key":"51351_CR46","doi-asserted-by":"publisher","first-page":"e008990","DOI":"10.1136\/bmjopen-2015-008990","volume":"5","author":"KS Ladha","year":"2015","unstructured":"Ladha, K. S. et al. The Deyo-Charlson and Elixhauser-van Walraven Comorbidity Indices as predictors of mortality in critically ill patients. BMJ Open. 5 (9), e008990 (2015).","journal-title":"BMJ Open."},{"issue":"4","key":"51351_CR47","first-page":"188","volume":"12","author":"WP Glasheen","year":"2019","unstructured":"Glasheen, W. P. et al. Charlson comorbidity index: ICD-9 update and ICD-10 translation. Am. Health Drug Benefits. 12 (4), 188\u2013197 (2019).","journal-title":"Am. Health Drug Benefits"},{"issue":"2","key":"51351_CR48","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1176\/appi.focus.20150042","volume":"14","author":"BW Dunlop","year":"2016","unstructured":"Dunlop, B. W. Evidence-based applications of combination psychotherapy and pharmacotherapy for depression. Focus 14 (2), 156\u2013173 (2016).","journal-title":"Focus"},{"issue":"9","key":"51351_CR49","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1001\/jamapsychiatry.2020.0770","volume":"77","author":"A McDowell","year":"2020","unstructured":"McDowell, A., Raifman, J., Progovac, A. M. & Rose, S. Association of nondiscrimination policies with mental health among gender minority individuals. JAMA Psychiatry. 77 (9), 952\u2013958 (2020).","journal-title":"JAMA Psychiatry"},{"key":"51351_CR50","doi-asserted-by":"publisher","first-page":"100233","DOI":"10.1016\/j.eclinm.2019.12.003","volume":"18","author":"K Hashimoto","year":"2020","unstructured":"Hashimoto, K. Impact of age on optimal dose of antidepressants. EClinicalMedicine 18, 100233 (2020).","journal-title":"EClinicalMedicine"},{"issue":"5","key":"51351_CR51","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1097\/00004583-200205000-00008","volume":"41","author":"MM Olfson","year":"2002","unstructured":"Olfson, M. M., Marcus, S., Weissman, M. & Jensen, P. National trends in the use of psychotropic medications by children. J. Am. Acad. Child. Adolesc. Psychiatry. 41 (5), 514\u2013521 (2002).","journal-title":"J. Am. Acad. Child. Adolesc. Psychiatry"},{"key":"51351_CR52","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.healthplace.2012.11.007","volume":"20","author":"M King","year":"2013","unstructured":"King, M. & Essick, C. The geography of antidepressant, antipsychotic, and stimulant utilization in the United States. Health Place. 20, 32\u201338 (2013).","journal-title":"Health Place"},{"issue":"5\u20136","key":"51351_CR53","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1080\/21678421.2024.2315185","volume":"25","author":"AA Hart","year":"2024","unstructured":"Hart, A. A., Swenson, A., Narayanan, N. S. & Simmering, J. E. Rurality modifies the association between symptoms and the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 25 (5\u20136), 517\u2013527 (2024).","journal-title":"Amyotroph. Lateral Scler. Front. Degener"},{"issue":"2","key":"51351_CR54","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/1475-6773.13096","volume":"54","author":"JM Graves","year":"2018","unstructured":"Graves, J. M. et al. Rural-urban disparities in health care costs and health service utilization following pediatric mild traumatic brain injury. Health Serv. Res. 54 (2), 337 (2018).","journal-title":"Health Serv. Res."},{"issue":"2\u20133","key":"51351_CR55","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1159\/000360229","volume":"65","author":"DS Nagin","year":"2014","unstructured":"Nagin, D. S. Group-based trajectory modeling: An overview. Ann. Nutr. Metab. 65 (2\u20133), 205\u2013210 (2014).","journal-title":"Ann. Nutr. Metab."},{"issue":"3","key":"51351_CR56","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/pds.4917","volume":"29","author":"RP Hickson","year":"2020","unstructured":"Hickson, R. P., Annis, I. E., Killeya-Jones, L. A. & Fang, G. Opening the black box of the group-based trajectory modeling process to analyze medication adherence patterns: An example using real-world statin adherence data. Pharmacoepidemiol. Drug Saf. 29 (3), 357\u2013362 (2020).","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"9","key":"51351_CR57","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1007\/s11606-016-3747-6","volume":"31","author":"WH Lo-Ciganic","year":"2016","unstructured":"Lo-Ciganic, W. H. et al. Trajectories of diabetes medication adherence and hospitalization risk: A retrospective cohort study in a large state medicaid program. J. Gen. Intern. Med. 31 (9), 1052\u20131060 (2016).","journal-title":"J. Gen. Intern. Med."},{"key":"51351_CR58","doi-asserted-by":"publisher","first-page":"100973","DOI":"10.1016\/j.ssmph.2021.100973","volume":"17","author":"KH Park","year":"2022","unstructured":"Park, K. H., Tickle, L. & Cutler, H. Identifying temporal patterns of adherence to antidepressants, bisphosphonates and statins, and associated patient factors. SSM Popul. Health. 17, 100973 (2022).","journal-title":"SSM Popul. Health"},{"issue":"1","key":"51351_CR59","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12874-022-01622-9","volume":"22","author":"M M\u00e9sidor","year":"2022","unstructured":"M\u00e9sidor, M., Rousseau, M. C., O\u2019Loughlin, J. & Sylvestre, M. P. Does group-based trajectory modeling estimate spurious trajectories? BMC Med. Res. Methodol. 22 (1), 194 (2022).","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"51351_CR60","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1590\/1516-4446-2020-0935","volume":"43","author":"M Solmi","year":"2020","unstructured":"Solmi, M. et al. How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations. Braz J. Psychiatry. 43 (2), 189\u2013202 (2020).","journal-title":"Braz J. Psychiatry"},{"issue":"5","key":"51351_CR61","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4172\/Neuropsychiatry.1000145","volume":"6","author":"DMJ Martin-Vazquez","year":"2016","unstructured":"Martin-Vazquez, D. M. J. Adherence to antidepressants: A review of the literature. Neuropsychiatry 6 (5), 236\u2013241 (2016).","journal-title":"Neuropsychiatry"},{"issue":"11","key":"51351_CR62","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00228-016-2106-1","volume":"72","author":"AC M\u00e5rdby","year":"2016","unstructured":"M\u00e5rdby, A. C. et al. Adherence to antidepressants among women and men described with trajectory models: a Swedish longitudinal study. Eur. J. Clin. Pharmacol. 72 (11), 1381\u20131389 (2016).","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"51351_CR63","first-page":"174550572412722","volume":"20","author":"R Ishiwata","year":"2024","unstructured":"Ishiwata, R., AlAshqar, A., Miyashita-Ishiwata, M. & Borahay, M. A. Dispensing patterns of antidepressant and antianxiety medications for psychiatric disorders after benign hysterectomy in reproductive-age women: Results from group-based trajectory modeling. Womens Health. 20, 17455057241272218 (2024).","journal-title":"Womens Health"},{"key":"51351_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jad.2015.12.029","volume":"193","author":"SC Ho","year":"2016","unstructured":"Ho, S. C., Chong, H. Y., Chaiyakunapruk, N., Tangiisuran, B. & Jacob, S. A. Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: A systematic review. J. Affect. Disord. 193, 1\u201310 (2016).","journal-title":"J. Affect. Disord"},{"issue":"5","key":"51351_CR65","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1331\/JAPhA.2013.12213","volume":"53","author":"PC Heaton","year":"2013","unstructured":"Heaton, P. C., Tundia, N. L. & Luder, H. R. U.S. emergency departments visits resulting from poor medication adherence: 2005-07. J. Am. Pharm. Assoc. JAPhA. 53 (5), 513\u2013519 (2013).","journal-title":"J. Am. Pharm. Assoc. JAPhA"},{"issue":"7488","key":"51351_CR66","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/bmj.330.7488.389","volume":"330","author":"C Martinez","year":"2005","unstructured":"Martinez, C. et al. Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study. BMJ 330 (7488), 389 (2005).","journal-title":"BMJ"},{"key":"51351_CR67","doi-asserted-by":"crossref","unstructured":"Smith K, Attenburrow MJ. Does drug treatment reduce the risk of further self-harm or suicide? Commentary on\u2026 Cochrane Corner. BJPsych Adv. 22(1), 3\u20137 (2016).","DOI":"10.1192\/apt.22.1.3"},{"issue":"1","key":"51351_CR68","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1370\/afm.2473","volume":"18","author":"AM Morenz","year":"2020","unstructured":"Morenz, A. M., Goldhammer, H., Lambert, C. A., Hopwood, R. & Keuroghlian, A. S. A Blueprint for planning and implementing a transgender health program. Ann. Fam Med. 18 (1), 73\u201379 (2020).","journal-title":"Ann. Fam Med."},{"issue":"4","key":"51351_CR69","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/JOM.0b013e318168efb7","volume":"50","author":"WJ Katon","year":"2008","unstructured":"Katon, W. J. & Seelig, M. Population-based care of depression: Team care approaches to improving outcomes. J. Occup. Environ. Med. 50 (4), 459 (2008).","journal-title":"J. Occup. Environ. Med."},{"key":"51351_CR70","unstructured":"Part, C. and D Performance Data | CMS [Internet]. [cited 2022 Oct 25]. https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovGenIn\/PerformanceData"},{"key":"51351_CR71","unstructured":"Adherence Measures [Internet]. [cited 2022 Oct 26]. https:\/\/www.pqaalliance.org\/adherence-measures"},{"key":"51351_CR72","unstructured":"Ecpstageadmin. ExactCare Pharmacy. [cited 2022 Oct 25]. How Medication Adherence Impacts Medicare Star Ratings. (2021). https:\/\/www.exactcarepharmacy.com\/about-exactcare\/news\/how-medication-adherence-impacts-medicare-star-ratings\/"},{"key":"51351_CR73","unstructured":"Trajectories of Diabetes Medication Adherence and Hospitalization Risk. A Retrospective Cohort Study in a Large State Medicaid Program\u2014PubMed. [cited 2023 Mar 20]. https:\/\/pubmed-ncbi-nlm-nih-gov.libproxy.lib.unc.edu\/27229000\/"},{"issue":"1","key":"51351_CR74","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12874-020-01199-1","volume":"21","author":"H Kim","year":"2021","unstructured":"Kim, H., Lee, J. T., Fong, K. C. & Bell, M. L. Alternative adjustment for seasonality and long-term time-trend in time-series analysis for long-term environmental exposures and disease counts. BMC Med. Res. Methodol. 21 (1), 2 (2021).","journal-title":"BMC Med. Res. Methodol."},{"issue":"2","key":"51351_CR75","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1353\/prv.2024.a934558","volume":"63","author":"D Alnabulsi","year":"2024","unstructured":"Alnabulsi, D. & Talbert, R. D. Disparities in health insurance and the intersection of race\/ethnicity, sexuality, and gender identity. Popul. Rev. 63 (2), 35\u201356 (2024).","journal-title":"Popul. Rev."},{"key":"51351_CR76","unstructured":"James, S. E., Herman, J., Keisling, M., Mottet, L. & Anafi, M. Transgender Survey (USTS): Version 1 [Internet]. Inter-University Consortium for Political and Social Research; 2019 [cited 2021 May 10]. (2015). U.S Available from: https:\/\/www.icpsr.umich.edu\/icpsrweb\/RCMD\/studies\/37229\/versions\/V1"},{"issue":"4","key":"51351_CR77","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/trgh.2020.0182","volume":"7","author":"KD Clark","year":"2022","unstructured":"Clark, K. D., Sherman, A. D. F. & Flentje, A. Health insurance prevalence among gender minority people: A systematic review and meta-analysis. Transgender Health. 7 (4), 292\u2013302 (2022).","journal-title":"Transgender Health"},{"issue":"7","key":"51351_CR78","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1093\/jamia\/ocy022","volume":"25","author":"JR Blosnich","year":"2018","unstructured":"Blosnich, J. R. et al. Using clinician text notes in electronic medical record data to validate transgender-related diagnosis codes. J. Am. Med. Inf. Assoc. JAMIA. 25 (7), 905\u2013908 (2018).","journal-title":"J. Am. Med. Inf. Assoc. JAMIA"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51351-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51351-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T09:02:37Z","timestamp":1786093357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-51351-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["51351"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-51351-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"16 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Study procedures were approved by the University of North Carolina at Chapel Hill Institutional Review Board. Clinical trial number: not applicable. Human Ethics and Consent to Participate declarations: not applicable.","order":2,"name":"Ethics","label":"IRB\/clinical trial\/human ethics and consent statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24468"}}